ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

XRTX XORTX Therapeutics Inc

2.58
-0.02 (-0.77%)
2024年5月25日 - 終了
15分遅延
名称 銘柄コード 市場 種別
XORTX Therapeutics Inc XRTX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.02 -0.77% 2.58 09:00:00
始値 安値 高値 終値 前日終値
2.70 2.56 2.76 2.58 2.60
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/1720:00GLOBEXORTX Reprices Balance of Warrants Issued in Connection with..
2024/5/1105:10EDGAR2Form 20-F - Annual and transition report of foreign private..
2024/5/0102:54GLOBEXORTX Reprices Warrants Issued in Connection with Previous..
2024/4/2220:00GLOBEXORTX Announces Publication of Key Research in ADPKD
2024/4/0820:30GLOBEXORTX Welcomes New Member to the Board of Directors
2024/4/0820:00GLOBEXORTX Announces Participation in Spring 2024 Investor..
2024/3/2718:00GLOBEXORTX Announces New Clinical Advisory Board Member
2024/3/1918:00GLOBEXORTX Highlights Achievements of 2023 and Preparation for..
2024/3/1120:00GLOBEXORTX Reprices Warrants Issued in Connection with Previous..
2024/3/0421:00GLOBEXORTX Finalizes $2.7 Million Prospectus Supplement and..
2024/2/1521:00GLOBEXORTX Raises $2.5 Million Under Prospectus Supplement and..
2024/2/0210:46GLOBEXORTX Files an Amended and Restated Prospectus Supplement..
2024/1/1521:00GLOBEXORTX Announces $2 Million Public Offering
2024/1/0321:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0321:00GLOBEXORTX Submits a New Patent for the Treatment of Chronic..
2024/1/0222:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0221:00GLOBEXORTX Welcomes New Member to the Board of Directors
2023/12/0106:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/3021:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/3021:30GLOBEXORTX Announces US ATM Offering
2023/11/3011:57EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/2921:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/2921:00GLOBEXORTX Meets Nasdaq Continued Listing Requirements
2023/11/1321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1021:00GLOBEXORTX Clarifies Timing for Share Consolidation
2023/11/0907:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0907:00GLOBEXORTX Announces Share Consolidation
2023/11/0220:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0220:00GLOBEXORTX Sponsored Study Presented at the American Society of..
2023/10/2806:30GLOBEXORTX Announces Results of Special Meeting of Shareholders
2023/10/2606:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/2606:00GLOBEXORTX Announces Date for Rescheduled Special Meeting of..
2023/10/2520:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/2520:00GLOBEXORTX Announces Rescheduling of Special Meeting of..
2023/10/1220:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/1220:00GLOBEXORTX Reports that Independent Proxy Firm, ISS, Recommends..
2023/10/0502:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/0420:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/0420:00GLOBEXORTX Calls Special Meeting of Shareholders
2023/9/2820:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/2820:00GLOBEXORTX Sponsored Study Selected for Presentation at the..
2023/9/1304:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/1120:00GLOBEXORTX Announces Participation at Upcoming Investor..
2023/9/0721:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/0720:00GLOBEXORTX Joins the Kidney Foundation and Kidney March
2023/8/2920:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/2920:00GLOBEXORTX Submits Orphan Drug Designation Application to the..
2023/8/2519:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1505:42EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1505:40EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]

最近閲覧した銘柄

Delayed Upgrade Clock